Evidence map›Paper›PMID 33281443›Full record

ReviewInternational journal of nanomedicine2020

Applications of Graphene and Graphene Oxide in Smart Drug/Gene Delivery: Is the World Still Flat?

Mojtaba Hoseini-Ghahfarokhi, Soroush Mirkiani, Naeimeh Mozaffari, Mohamad Amin Abdolahi Sadatlu, Amir Ghasemi, Somayeh Abbaspour, Mohsen Akbarian, Fatemeh Farjadian, Mahdi Karimi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 221 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Graphene Oxide: Preparation and Medical Research.Materials (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

Mojtaba Hoseini-GhahfarokhiNano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.ORCID 0000-0003-4887-4842
Soroush MirkianiNeuroscience and Mental Health Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.ORCID 0000-0001-9328-4222
Naeimeh MozaffariResearch School of Electrical, Energy and Materials Engineering, The Australian National University, Canberra 2601, Australia.ORCID 0000-0002-8361-6470
Mohamad Amin Abdolahi SadatluDepartment of Engineering and Science, Sharif University of Technology-International Campus, Kish, Iran.
Amir GhasemiDepartment of Engineering, Durham University, Durham DH1 3LE, United Kingdom.
Somayeh AbbaspourDepartment of Engineering, Durham University, Durham DH1 3LE, United Kingdom.
Mohsen AkbarianPharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Fatemeh FarjadianPharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Mahdi KarimiIran Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-7977-3940
Iran University of Medical Sciences · IRShiraz University of Medical Sciences · IRAustralian National University · AUDurham University · GBKermanshah University of Medical Sciences · IRSharif University of Technology · IRUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graphene, a wonder material, has made far-reaching developments in many different fields such as materials science, electronics, condensed physics, quantum physics, energy systems, etc. Since its discovery in 2004, extensive studies have been done for understanding its physical and chemical properties. Owing to its unique characteristics, it has rapidly became a potential candidate for nano-bio researchers to explore its usage in biomedical applications. In the last decade, remarkable efforts have been devoted to investigating the biomedical utilization of graphene and graphene-based materials, especially in smart drug and gene delivery as well as cancer therapy. Inspired by a great number of successful graphene-based materials integrations into the biomedical area, here we summarize the most recent developments made about graphene applications in biomedicine. In this paper, we review the up-to-date advances of graphene-based materials in drug delivery applications, specifically targeted drug/ gene delivery, delivery of antitumor drugs, controlled and stimuli-responsive drug release, photodynamic therapy applications and optical imaging and theranostics, as well as investigating the future trends and succeeding challenges in this topic to provide an outlook for future researches.

Indexed as

Gene Transfer TechniquesAnimalsAntineoplastic AgentsDrug CarriersGraphiteHumansPhotochemotherapyAntineoplastic AgentsDrug Carriersgraphene oxideGraphitecancer therapydrug deliverygene deliverygraphenegraphene oxidephotodynamic therapy

Identifiers

PMID33281443
PMCPMC7710865
OpenAlexW3108697356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.